$0.016000
00.00%
At close: Sep 29, 3:59 PM EDT
$0.022300
0.006339.38%
After Hours: Sep 19, 4:01 PM EDT
15 minutes delayed
Comments
Loading...
Infinity Pharmaceuticals Inc (OTC:INFI) Stock, Earnings Estimates, EPS, And Revenue
Infinity Pharmaceuticals Inc reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 10
EPS
$-0.110
Quarterly Revenue
$583K
Annual Revenue
–
Analyze the earnings history of Infinity Pharmaceuticals Inc using advanced sorting and filters.
Data brought to you by Benzinga APIs
Infinity Pharmaceuticals Inc (INFI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2023 | 2023-08-10 | $-0.11 | $-0.12 | 8.33 % |
| Mar 2023 | 2023-05-09 | $-0.12 | $-0.10 | -20.0 % |
| Dec 2022 | 2023-03-28 | $-0.11 | $-0.03 | -266.7 % |
| Sep 2022 | 2022-11-14 | $-0.12 | $-0.06 | -100.0 % |
Infinity Pharmaceuticals Inc (INFI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2023 | 2023-08-10 | $583.00K | $583.00K | 0.00 % |
| Mar 2023 | 2023-05-09 | $731.00K | $300.00K | 143.7 % |
| Dec 2022 | 2023-03-28 | $543.00K | $600.00K | -9.50 % |
| Sep 2022 | 2022-11-14 | $712.00K | $6.19M | -88.5 % |
FAQ
When is Infinity Pharmaceuticals Inc (OTC:INFI) reporting earnings?
Infinity Pharmaceuticals Inc (INFI) is scheduled to report earnings on October 1, 2024. The last reported earnings were for reported on August 10, 2023 for Q2.
What were the latest earnings per share (EPS) for Infinity Pharmaceuticals Inc (OTC:INFI)?
The Actual EPS was $-0.11, which beat the estimate of $-0.12.
What were Infinity Pharmaceuticals Inc’s (OTC:INFI) revenues?
The Actual Revenue was $583K, which hit the estimate of $583K.
Browse earnings estimates, EPS, and revenue on all stocks.